Common Contracts
2 similar License Agreement contracts by Lirum Therapeutics, Inc.
LICENSE AGREEMENTLicense Agreement • February 2nd, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations • New York
This license agreement (this “Agreement”) is entered into as of January 12, 2022 (the “Effective Date”) by and between IGF Oncology, LLC, a Delaware limited liability company, having an address of 7460 Pinehurst Road, Saint Paul, MN 55115 (“IGF”) and Lirum Therapeutics, Inc. a Delaware corporation, having an address of 590 Park Avenue, New York, NY 10065 (“LIRUM”). IGF and LIRUM are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • June 20th, 2023 • Lirum Therapeutics, Inc. • Pharmaceutical preparations • New York
This license agreement (this “Agreement”) is entered into as of January 12, 2022 (the “Effective Date”) by and between IGF Oncology, LLC, a Delaware limited liability company, having an address of [***] (“IGF”) and Lirum Therapeutics, Inc. a Delaware corporation, having an address of 590 Park Avenue, New York, NY 10065 (“LIRUM”). IGF and LIRUM are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.
